FDA Inspection 1072028 — Pearlman, David M.D

Pearlman, David M.D — FEI 3006048669

The FDA completed an inspection of Pearlman, David M.D on Aug 16, 2018 in Denver, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Denver, CO (United States)

Additional Details

Clinical BA/BE